Eloctate
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
225 2nd Ave, Waltham, Massachusetts, 024...Phone Number
(781) 663-2868Website
www.eloctate.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Eloctate
Learn about ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longerExplore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eloctate your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Eloctate, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Eloctate has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Eloctate is spiking on competitors!
Click to see if Eloctate had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Eloctate
Check if Eloctate has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Eloctate recently announced quarterly report
Product Launch: Get notified when Eloctate launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Eloctate
Compare insights from companies similar to Eloctate, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Eloctate
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Eloctate is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eloctate is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eloctate.
Eloctate Tech Stack
A closer look at the technologies used by Eloctate
Eloctate News & Media
At ASH, Extended Half-Life Therapies ELOCTATE® and ALPROLIX® Demonstrate Proven Efficacy and Well-Characterized Safety over Four Years
SAN DIEGO--(BUSINESS WIRE)--Bioverativ Inc., a Sanofi company, and Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announced the final results of ASPIRE and B-YOND, the most comprehensive long-term studies of extended half-life factor therapies in hemophilia. The data from both studies confirm the established safety and sustained efficacy of ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein], marketed as Elocta® in Europe and the Middle East, and ALPROLIX® [CoagulatiNew Data at ASH Showcase Bioverativ’s Commitment to Transforming Care for People with Hemophilia and Other Rare Blood Disorders
WALTHAM, Mass.--(BUSINESS WIRE)--Bioverativ Inc., a Sanofi company dedicated to transforming the lives of people with rare blood disorders, today announced it will present data demonstrating its commitment to improving the care of people with hemophilia and other rare blood disorders like sickle cell disease at the 60th Annual Meeting of the American Society of Hematology (ASH), December 1 - 4 in San Diego, California. “The new data we are presenting at ASH highlight our commitment
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eloctate
Sign Up For FreeTo access detailed company insights
Learn about ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer... Read More
